ArticleScientific reports2019

Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine.

Michiko Imamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.